ELIZABETH CLARK: Open Payments
NPI 1316368848 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,764 in 113 payments from 14 companies in 2025. Trend: 2023 $2,717 · 2024 $2,328 · 2025 $2,764
Food & beverage: $2,653Education: $111
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $469 |
| ABBVIE INC. | 27 | $441 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $421 |
| Teva Pharmaceuticals USA, Inc. | 7 | $333 |
| Otsuka America Pharmaceutical, Inc. | 15 | $260 |
| Vanda Pharmaceuticals Inc. | 10 | $224 |
| Axsome Therapeutics, Inc. | 6 | $219 |
| E.R. Squibb & Sons, L.L.C. | 6 | $111 |
| Alkermes, Inc. | 5 | $109 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, FANAPT, SPRAVATO, Auvelity, REXULTI, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
